Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 07, 2015 11:41 AM ET

Pharmaceuticals

Company Overview of Horizon Pharma plc

Company Overview

Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally. It offers ACTIMMUNE for reducing the frequency and severity of serious infections associated with chronic granulomatous disease; DUEXIS, a proprietary tablet formulation for the relief of signs and symptoms of rheumatoid arthritis (RA) and osteoarthritis (OA), and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for these indications; PENNSAID for the treatment of pain of OA ...

Connaught House

1st Floor

1 Burlington Road

Dublin,  4

Ireland

Founded in 2005

605 Employees

Phone:

353 1 772 2100

Key Executives for Horizon Pharma plc

Chairman, Chief Executive Officer and President
Age: 48
Total Annual Compensation: $982.3K
Chief Financial Officer and Executive Vice President of Finance
Age: 50
Total Annual Compensation: $210.9K
Chief Business Officer and Executive Vice President
Age: 56
Total Annual Compensation: $492.0K
Chief Medical Officer and Executive Vice President of Research & Development
Age: 60
Total Annual Compensation: $396.3K
Chief Commercial Officer and Executive Vice President
Age: 47
Total Annual Compensation: $194.5K
Compensation as of Fiscal Year 2014.

Horizon Pharma plc Key Developments

Horizon Pharma plc(NasdaqGS:HZNP) dropped from Russell 2000 Index

Horizon Pharma plc will be removed from Russell 2000 Index

Horizon Pharma plc(NasdaqGS:HZNP) dropped from Russell 3000 Index

Horizon Pharma plc will be removed from Russell 3000 Index.

Horizon Pharma plc Presents at BIO International Convention 2015, Jun-18-2015 09:45 AM

Horizon Pharma plc Presents at BIO International Convention 2015, Jun-18-2015 09:45 AM. Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States.

Similar Private Companies By Industry

Company Name Region
Transition Therapeutics Ireland Limited Europe
Clonmel Healthcare Limited Europe
Mylan Institutional LLC Europe
Takeda Ireland Limited Europe
Daravita Limited Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Horizon Pharma plc, please visit www.horizonpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.